134 related articles for article (PubMed ID: 11472355)
1. High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system.
Kjalke M; Ezban M; Monroe DM; Hoffman M; Roberts HR; Hedner U
Br J Haematol; 2001 Jul; 114(1):114-20. PubMed ID: 11472355
[TBL] [Abstract][Full Text] [Related]
2. The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation.
Gerotziafas GT; Chakroun T; Depasse F; Arzoglou P; Samama MM; Elalamy I
Thromb Haemost; 2004 May; 91(5):977-85. PubMed ID: 15116259
[TBL] [Abstract][Full Text] [Related]
3. Effect of recombinant factor VIIa (Novoseven) on thrombocytopenia-like conditions in vitro.
Kjalke M; Johannessen M; Hedner U
Semin Hematol; 2001 Oct; 38(4 Suppl 12):15-20. PubMed ID: 11735105
[TBL] [Abstract][Full Text] [Related]
4. General haemostatic agents--fact or fiction?
Hedner U
Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():33-6. PubMed ID: 12214145
[TBL] [Abstract][Full Text] [Related]
5. Thrombin generation and platelet activation induced by rFVIIa (NovoSeven) and NN1731 in a reconstituted cell-based model mimicking haemophilia conditions.
Aljamali MN; Kjalke M; Hedner U; Ezban M; Tranholm M
Haemophilia; 2009 Nov; 15(6):1318-26. PubMed ID: 19659796
[TBL] [Abstract][Full Text] [Related]
6. Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count.
Lisman T; Adelmeijer J; Cauwenberghs S; Van Pampus EC; Heemskerk JW; De Groot PG
J Thromb Haemost; 2005 Apr; 3(4):742-51. PubMed ID: 15842358
[TBL] [Abstract][Full Text] [Related]
7. Potential role of recombinant factor VIIa as a hemostatic agent.
Hedner U; Erhardtsen E
Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
[TBL] [Abstract][Full Text] [Related]
8. Experiences with recombinant human factor VIIa in patients with thrombocytopenia.
Goodnough LT
Semin Hematol; 2004 Jan; 41(1 Suppl 1):25-9. PubMed ID: 14872417
[TBL] [Abstract][Full Text] [Related]
9. Activation of platelets in whole blood by recombinant factor VIIa by a thrombin-dependent mechanism.
Wilbourn B; Harrison P; Mackie IJ; Liesner R; Machin SJ
Br J Haematol; 2003 Aug; 122(4):651-61. PubMed ID: 12899721
[TBL] [Abstract][Full Text] [Related]
10. Understanding the therapeutic action of recombinant factor VIIa in platelet disorders.
Hers I; Mumford A
Platelets; 2008 Dec; 19(8):571-81. PubMed ID: 19012175
[TBL] [Abstract][Full Text] [Related]
11. A novel approach to improving recombinant factor VIIa activity with a preserved platelet preparation.
Campbell RA; Fischer TH; Wolberg AS
Br J Haematol; 2007 Jul; 138(1):82-93. PubMed ID: 17555451
[TBL] [Abstract][Full Text] [Related]
12. Sustained pro-haemostatic activity of rFVIIa in plasma and platelets in non-bleeding pigs may explain the efficacy of a once-daily prophylaxis in humans.
Schut AM; Hyseni A; Adelmeijer J; Meijers JC; De Groot PG; Lisman T
Thromb Haemost; 2014 Aug; 112(2):304-10. PubMed ID: 24695949
[TBL] [Abstract][Full Text] [Related]
13. Enhanced thrombin generation in plasma of severe thrombocytopenic patients due to rFVIIa.
Novak M; Hiden M; Rehak T; Rosenkranz A; Zebisch A; Sill H; Klaschka S; Muntean W
Hamostaseologie; 2008 Oct; 28 Suppl 1():S77-80. PubMed ID: 18958344
[TBL] [Abstract][Full Text] [Related]
14. Combination of recombinant factor VIIa and fibrinogen corrects clot formation in primary immune thrombocytopenia at very low platelet counts.
Larsen OH; Stentoft J; Radia D; Ingerslev J; Sørensen B
Br J Haematol; 2013 Jan; 160(2):228-36. PubMed ID: 23151086
[TBL] [Abstract][Full Text] [Related]
15. Platelet-dependent thrombin generation assay for monitoring the efficacy of recombinant Factor VIIa.
Wegert W; Harder S; Bassus S; Kirchmaier CM
Platelets; 2005 Feb; 16(1):45-50. PubMed ID: 15763896
[TBL] [Abstract][Full Text] [Related]
16. A variant of recombinant factor VIIa with enhanced procoagulant and antifibrinolytic activities in an in vitro model of hemophilia.
Allen GA; Persson E; Campbell RA; Ezban M; Hedner U; Wolberg AS
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):683-9. PubMed ID: 17204663
[TBL] [Abstract][Full Text] [Related]
17. Whole blood coagulation in children with thrombocytopenia and the response to platelet replacement, recombinant factor VIIa, and a potent factor VIIa analogue.
Larsen OH; Clausen N; Persson E; Ezban M; Ingerslev J; Sørensen B
Br J Haematol; 2009 Jan; 144(1):99-106. PubMed ID: 19016728
[TBL] [Abstract][Full Text] [Related]
18. On the mechanism of action of recombinant activated factor VII administered to patients with severe thrombocytopenia and life-threatening haemorrhage: focus on prothrombin activation.
Gerotziafas GT; Zervas K; Arzoglou P; Karavaggeli E; Parashou S; Van Dreden P; Christakis J; Samama MM
Br J Haematol; 2002 Jun; 117(3):705-8. PubMed ID: 12028045
[TBL] [Abstract][Full Text] [Related]
19. Neonatal thrombocytopenia: Thrombin generation in presence of reduced platelet counts and effects of rFVIIa in cord blood.
Haidl H; Pohl S; Leschnik B; Gallistl S; Muntean W; Schlagenhauf A
Sci Rep; 2019 May; 9(1):8014. PubMed ID: 31142810
[TBL] [Abstract][Full Text] [Related]
20. Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophilia.
Allen GA; Hoffman M; Roberts HR; Monroe DM
Br J Haematol; 2006 Aug; 134(3):314-9. PubMed ID: 16787497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
